BCL2 and breast cancer: PTEN expression in breast cancer cell lines has also shown to significantly inhibit the phosphorylation and DNA binding activity of NF-kB and transcription of its downstream targets which include VEGF and antiapoptotic genes Bcl-2 and Bcl-xL [15].